Apidra injection 100 units/mL contains insulin glulisine (recombinant), a rapid-acting insulin produced by Sanofi, for controlling high blood sugar in adults and children with diabetes mellitus. This injectable drug, with YJ code 2492418A1024, is supplied as 100 units per 1 mL vial.
Apidra injection 100 units/mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →